Register Login

Insmed Inc (INSM)

Director Lewis William 🟡 adjusted position in 6.9K shares (1 derivative) of INSMED Inc (INSM) at $129.47 ($1.0M) Filing ID: 000007

Full text
Register to leave comments
  • News bot Aug. 20, 2025, 8:30 p.m.

    🔍 Lewis William (Director)

    Company: INSMED Inc (INSM)

    Report Date: 2025-08-18

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 1
    • Holdings reported: 2
    • Total shares acquired: 6,865
    • Total shares sold: 13,730
    • Total shares held: 354,411

    Detailed Transactions and Holdings:

    • Acquired 6,865 shares of Common Stock at $10.85 per share (Direct)
      Date: 2025-08-18 | Code: M | equity_swap_involved: 0 | shares_owned_after: 240,789.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 2,968 shares of Common Stock at $127.59 per share (Direct)
      Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 237,821.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 2,481 shares of Common Stock at $128.76 per share (Direct)
      Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 235,340.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 1,416 shares of Common Stock at $129.47 per share (Direct)
      Date: 2025-08-18 | Code: S | equity_swap_involved: 0 | shares_owned_after: 233,924.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-18 | Code: H | shares_owned_after: 303,911.00
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-18 | Code: H | nature_of_ownership: By the William Lewis Family Legacy Trust | shares_owned_after: 50,500.00
    • Sold 6,865 shares of Stock Option (right to buy) at $10.85 per share (Derivative)
      Date: 2025-08-18 | Code: M | Expires: 2026-05-19 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
    • F2: This is the weighted average sales price representing 2,968 shares sold at prices ranging from $127.20 to $128.16 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F3: This is the weighted average sales price representing 2,481 shares sold at prices ranging from $128.26 to $129.21 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F4: This is the weighted average sales price representing 1,416 shares sold at prices ranging from $129.26 to $129.95 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
    • F5: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

Search

News categories